AccueilHow stem cells therapies are reshaping medical and research pathways?
EUCelLEX - 1st International Consensus Conference
Publié le mardi 17 février 2015 par Céline Guilleux
This event will cover a vast range of topics, regarding "How stem cells therapies are reshaping medical and research pathways?". This conference will be the occasion to organise two parallel workshops, on "Legal classifications of cell products" and "Values and representations around stem cells", in order to draw up some preliminary recommendations.
The European EUCelLEX Project (FP7- Cell-based regenerative medicine: new challenges for EU legislation and governance) consists in a full examination of the application of the European rules regarding cell banks together with current practices in respect of the therapeutic use of human cells in some European countries.
This project is coordinated by Inserm and involves nine partners based in seven European countries and Canada:
- Inserm UMR1027(coordinator), and Biobanques (Inserm US013) France: http://www.inserm.fr/
- Leibniz University, Germany: http://www.uni-hannover.de/en/index.php
- Central European University, Hungary: http://www.ceu.hu/
- Legal Pathway, Netherlands
- Oxford University, England: http://www.oP.ac.uk/
- Medical University of Graz, Austria: http://www.meduni-graz.at/en/
- National Political Sciences Foundation, France: http://www.sciencespo.fr/
- KU Leuven, Belgium: http://www.kuleuven.be/english/
- McGill University, Canada: http://www.mcgill.ca/fr
This project aims at building and at organising a Task force on Stem Cells in Europe for collecting facts and figures to assess the current legislation on the therapeutic use of cells, and to bridge it with research infrastructure capacity building. This International Conference represents the starting point to build our Task force and to propose preliminary recommendations to the European Commission.
The EUCelLEX first International Conference of consensus will cover a vast range of topics, related to “How stem cells therapies are reshaping medical & research pathways?”
This conference will be the occasion to organise two parallel workshops, on “Legal classifications of cell products” and “Values and representations around stem cells”, in order to draw up some preliminary recommendations.
Monday, 30 March 2015
12:30 – 13:30. Inscription
13:30 – 15:00. Plenary session
- Institutional welcome.
- Welcome & presentation of the EUCelLEX project. Emmanuelle RIAL-SEBBAG (Inserm U1027 – UPS Toulouse 3).
- Latest scientific discoveries and trends: actual state of the art on cellular therapies. Luc SENSEBE (STROMALab, UMR5273 CNRS/EFS/UPS – INSERM U1031 Toulouse).
15:30 – 17:30. Plenary session
- International Stem Cell policy: Quo Vadis. Bartha Maria KNOPPERS (CRDP – Université de Montréal).
- Challenges in translational research. Paolo BIANCO (University of Roma "La Sapienza").
Tuesday, 31 March 2015
9:00 – 12:30. Parallel Workshops
- WS 1: Legal classifications of cell products
Moderator: Nils HOPPE (Leibniz Universitaet Hannover)
Expert Observer: Nicolas FERRY (ANSM France)
- Cell products categorization;
- Hospital exception;
- Status of the donor;
- Commercial issues;
- Public/private partnerships;
- Harmonisation of European legal standards;
- Risks and responsabilities;
- Informed consent and capacity to consent;
- Stem cell tourism.
- WS 2: Values and representations around stem cells
Moderator: Alessandro BLASIMME (Inserm U1027 – UPS Toulouse 3
Expert Observer: Ingrid METZLER (University of Vienna)
- European biobanks policy & governance;
- Moral status of human embryos and other types of cells;
- Political influences on stem cell research;
- Ethical issues of imported bodily material;
- Public perceptions on stem cell research and regenerative medicine;
- Clinical research ethics in regenerative medicine;
- Ethics of unproven therapies;
- Patients' activism and advanced therapies;
- Commercial and IP aspects in regenerative medicine;
- Ethics of compassionate use and hospital exemption of advanced therapies
13:30 – 16:30. Round Table
- Outputs from the WS 1 & 2
Moderator: Anne CAMBON-THOMSEN (Inserm U1027 – UPS Toulouse 3)
Expert: Joana NAMORADO (DG Research & Innovation, European Commission) (to be confirmed)
16:30 – 17:30. Conclusions.
- Tim CAULFIELD (University of Alberta)
Conference attendance is free but requires registration (sessions limited to 100 people). Registration includes attendance to all sessions, to the conference material, to lunch and refreshments.
Please register your details online.
Until March 1, 2015 : conference registration
- Hospital Pierre Paul Riquet - avenue Professeur Dausset
Toulouse, France (31059)
- lundi 30 mars 2015
- mardi 31 mars 2015
- Cell-based regenerative medicine, legislation, governance, ethic, value, representation
- Rosario Sánchez-Albor
courriel : contact [at] eucellex [dot] eu
URLS de référence
Source de l'information
- Emmanuelle Rial-Sebbag
courriel : contact [at] eucellex [dot] eu
Pour citer cette annonce
« How stem cells therapies are reshaping medical and research pathways? », Colloque, Calenda, Publié le mardi 17 février 2015, http://calenda.org/317807